Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Abdominal Radiology
Published in: Abdominal Radiology 6/2015

01-08-2015 | Pictorial Essay

PET/MRI for the body imager: abdominal and pelvic oncologic applications

Authors: Tyler J. Fraum, Kathryn J. Fowler, Jon McConathy, Ephraim E. Parent, Farrokh Dehdashti, Perry W. Grigsby, Barry A. Siegel

Published in: Abdominal Radiology | Issue 6/2015

Login to get access

Abstract

The purpose of this pictorial review is to describe emerging clinical applications of positron emission tomography (PET)/magnetic resonance imaging (MRI), the newest clinical hybrid imaging modality, with a specific focus on abdominal and pelvic malignancies. Important issues regarding the clinical implementation of PET/MRI systems, including workflow considerations and protocol development, are examined. The unique technical challenges of simultaneous PET/MRI acquisition and MRI-based attenuation correction are also briefly discussed. This article is intended to provide the body imager with an overview of the potential diagnostic advantages of PET/MRI, as compared to PET/CT or MRI alone.
Literature
1.
Delso G, Ziegler S (2009) PET/MRI system design. Eur J Nucl Med Mol Imaging 36:86–92CrossRef
2.
Kalemis A, Delattre BMA, Heinzer S (2013) Sequential whole-body PET/MR scanner: concept, clinical use, and optimisation after two years in the clinic. the manufacturer’s perspective. Magn Reson Mater Phys Biol Med 26:5–23CrossRef
3.
Zaidi H, Del Guerra A (2011) An outlook on future design of hybrid PET/MRI systems. Med Phys 38:5667PubMedCrossRef
4.
5.
Lecomte R, Cadorette J, Rodrigue S, et al. (1996) Initial results from the sherbrooke avalanche photodiode positron tomograph. IEEE Trans Nucl Sci 43:1952–1957CrossRef
6.
Catana C, Wu Y, Judenhofer M (2006) Simultaneous acquisition of multislice PET and MR images: initial results with a MR-compatible PET scanner. J Nucl 1968–1976
7.
Yoon HS, Ko GB, Kwon S, et al. (2012) Initial results of simultaneous PET/MRI experiments with an MRI-compatible silicon photomultiplier PET scanner. J Nucl Med 53:608–614PubMedCrossRef
8.
Thompson CJ, Paus T, Clancy R (1998) Magnetic shielding requirements for PET detectors during transcranial magnetic stimulation. IEEE Trans Nucl Sci . doi:10.​1109/​23.​682021
9.
Hong SJ, Song IC, Ito M, et al. (2008) An investigation into the use of geiger-mode solid-state photomultipliers for simultaneous PET and MRI acquisition. IEEE Trans Nucl Sci 55:882–888CrossRef
10.
Leibfarth S, Mönnich D, Welz S, et al. (2013) A strategy for multimodal deformable image registration to integrate PET/MR into radiotherapy treatment planning. Acta Oncol 52:1353–1359PubMedCrossRef
11.
Schreibmann E, Nye JA, Schuster DM, et al. (2010) MR-based attenuation correction for hybrid PET-MR brain imaging systems using deformable image registration. Med Phys 37:2101–2109PubMedCrossRef
12.
13.
Würslin C, Schmidt H, Martirosian P, et al. (2013) Respiratory motion correction in oncologic PET using T1-weighted MR imaging on a simultaneous whole-body PET/MR system. J Nucl Med 54:464–471PubMedCrossRef
14.
Kolbitsch C, Prieto C, Tsoumpas C, et al. (2014) A 3D MR-acquisition scheme for nonrigid bulk motion correction in simultaneous PET-MR. Med Phys 41:082304PubMedCrossRef
15.
Pépin A, Daouk J, Bailly P, et al. (2014) Management of respiratory motion in PET/computed tomography: the state of the art. Nucl Med Commun 35:113–122PubMedCentralPubMedCrossRef
16.
Rakheja R, DeMello L, Chandarana H, et al. (2013) Comparison of the accuracy of PET/CT and PET/MRI spatial registration of multiple metastatic lesions. AJR Am J Roentgenol 201:1120–1123PubMedCrossRef
17.
Hofmann M, Bezrukov I, Mantlik F, et al. (2011) MRI-based attenuation correction for whole-body PET/MRI: quantitative evaluation of segmentation- and atlas-based methods. J Nucl Med 52:1392–1399PubMedCrossRef
18.
Hofmann M, Steinke F, Scheel V, et al. (2008) MRI-based attenuation correction for PET/MRI: a novel approach combining pattern recognition and atlas registration. J Nucl Med 49:1875–1883PubMedCrossRef
19.
Fowler KJ, McConathy J, Narra VR (2014) Whole-body simultaneous positron emission tomography (PET)-MR: optimization and adaptation of MRI sequences. J Magn Reson Imaging 39:259–268PubMedCrossRef
20.
21.
Keereman V, Fierens Y, Broux T, et al. (2010) MRI-based attenuation correction for PET/MRI using ultrashort echo time sequences. J Nucl Med 51:812–818PubMedCrossRef
22.
Drzezga A, Souvatzoglou M, Eiber M, et al. (2012) First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses. J Nucl Med 53:845–855PubMedCrossRef
23.
Tian J, Fu L, Yin D, et al. (2014) Does the novel integrated PET/MRI offer the same diagnostic performance as PET/CT for oncological indications? PLoS One 9:e90844PubMedCentralPubMedCrossRef
24.
Heusch P, Nensa F, Schaarschmidt B, et al. (2014) Diagnostic accuracy of whole-body PET/MRI and whole-body PET/CT for TNM staging in oncology. Eur J Nucl Med Mol Imaging. doi:10.​1007/​s00259-014-2885-5
25.
Aznar MC, Sersar R, Saabye J, et al. (2014) Whole-body PET/MRI: the effect of bone attenuation during MR-based attenuation correction in oncology imaging. Eur J Radiol 83:1177–1183PubMedCrossRef
26.
Izquierdo-Garcia D, Sawiak SJ, Knesaurek K, et al. (2014) Comparison of MR-based attenuation correction and CT-based attenuation correction of whole-body PET/MR imaging. Eur J Nucl Med Mol Imaging 41:1574–1584PubMedCentralPubMedCrossRef
27.
Eiber M, Takei T, Souvatzoglou M, et al. (2014) Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions. J Nucl Med 55:191–197PubMedCrossRef
28.
Ferguson A, McConathy J, Su Y, Hewing D, Laforest R (2014) Attenuation Effects of MR Headphones During Brain PET/MR Studies. J Nucl Med Technol 42:93–100PubMedCrossRef
29.
Von Schulthess GK, Veit-Haibach P (2014) Workflow Considerations in PET/MR Imaging. J Nucl Med 55:19S–24SCrossRef
30.
31.
Gu J, Chan T, Zhang J, et al. (2011) Whole-body diffusion-weighted imaging: the added value to whole-body MRI at initial diagnosis of lymphoma. Am J Roentgenol. doi:10.​2214/​AJR.​10.​5692
32.
Abdulqadhr G, Molin D, Aström G, et al. (2011) Whole-body diffusion-weighted imaging compared with FDG-PET/CT in staging of lymphoma patients. Acta Radiol 52:173–180PubMedCrossRef
33.
Siegel MJ, Jokerst CE, Rajderkar D, et al. (2014) Diffusion-weighted MRI for staging and evaluation of response in diffuse large B-cell lymphoma: a pilot study. NMR Biomed 27:681–691PubMedCentralPubMedCrossRef
34.
Shin SS, Jeong YY, Min JJ, et al. (2008) Preoperative staging of colorectal cancer: CT vs. integrated FDG PET/CT. Abdom Imaging 33:270–277PubMedCrossRef
35.
Olsen JR, Esthappan J, Dewees T, et al. (2013) Tumor volume and subvolume concordance between FDG-PET/CT and diffusion-weighted MRI for squamous cell carcinoma of the cervix. J Magn Reson Imaging 37:431–434PubMedCentralPubMedCrossRef
36.
Ho KC, Lin G, Wang JJ, et al. (2009) Correlation of apparent diffusion coefficients measured by 3T diffusion-weighted MRI and SUV from FDG PET/CT in primary cervical cancer. Eur J Nucl Med Mol Imaging 36:200–208PubMedCrossRef
37.
Fosse P, Girault S, Hoareau J, et al. (2013) Unusual uptake of 18FDG by a hepatic adenoma. Clin Nucl Med 38:135–136PubMedCrossRef
38.
Iyer RB, Balachandran A, Devine CE (2007) PET/CT and cross sectional imaging of gynecologic malignancy. Cancer Imaging 7 Spec No A:S130–S138PubMedCrossRef
39.
Dujardin M, Vandenbroucke F, Boulet C, et al. (2008) Indications for body MRI Part I. Upper abdomen and renal imaging. Eur J Radiol 65:214–221PubMedCrossRef
40.
Attariwala R, Picker W (2013) Whole body MRI: improved lesion detection and characterization with diffusion weighted techniques. J Magn Reson Imaging 38:253–268PubMedCentralPubMedCrossRef
41.
42.
Donati OF, Hany TF, Reiner CS, et al. (2010) Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI. J Nucl Med 51:692–699PubMedCrossRef
43.
Kitajima K, Suenaga Y, Ueno Y, et al. (2013) Value of fusion of PET and MRI for staging of endometrial cancer: comparison with 18F-FDG contrast-enhanced PET/CT and dynamic contrast-enhanced pelvic MRI. Eur J Radiol 82:1672–1676PubMedCrossRef
44.
Kitajima K, Suenaga Y, Ueno Y, et al. (2014) Fusion of PET and MRI for staging of uterine cervical cancer: comparison with contrast-enhanced (18)F-FDG PET/CT and pelvic MRI. Clin Imaging 38:464–469PubMedCrossRef
Metadata
Title
PET/MRI for the body imager: abdominal and pelvic oncologic applications
Authors
Tyler J. Fraum
Kathryn J. Fowler
Jon McConathy
Ephraim E. Parent
Farrokh Dehdashti
Perry W. Grigsby
Barry A. Siegel
Publication date
01-08-2015
Publisher
Springer US
Published in
Abdominal Radiology / Issue 6/2015
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-015-0390-3

Other articles of this Issue 6/2015

Abdominal Radiology 6/2015 Go to the issue

Classics in Abdominal Imaging

The onion ring sign

Review Article

How does PET/MR work? Basic physics for physicians

OriginalPaper

CT evaluation of common duct dilation after cholecystectomy and with advancing age

Pictorial Essay

Radiologic features of pancreatic and biliary complications following composite visceral transplantation

OriginalPaper

Simultaneous 68Ga-DOTA-TOC PET/MRI with gadoxetate disodium in patients with neuroendocrine tumor

Pictorial Essay

Central element in liver masses, helpful, or pitfall?
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits